AB0285 PREDICTORS OF UNACCEPTABLE PAIN, AND UNACCEPTABLE PAIN WITH LOW INFLAMMATION, IN EARLY RHEUMATOID ARTHRITIS. (June 2019)

• Record Type: Journal Article
• Authors: Eberhard, Anna; Olofsson, Tor; Jacobsson, Lennart T.H.; Turesson, Carl
• Is Part Of: Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
• Page Start: 1600
• Page End: 1600
• Publication Date: 2019-06
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2019-eular.3627
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Pain is a major symptom in many patients with rheumatoid arthritis (RA). In early RA, pain is usually due to active synovitis, but over the disease course some patients experience pain without elevated laboratory markers of inflammation. Objectives: To investigate predictors of unacceptable pain, and unacceptable pain with low inflammation, in patients with early RA. Methods: Consecutive patients with early RA (symptom duration <12 months), recruited in 1995-2005 from a defined area, were followed through 5 years. Patients were managed according to usual care, with no pre-specified treatment protocol. Pain was assessed using a visual analogue scale (VAS; 0-100 mm). Unacceptable pain was defined as VAS pain>40 based on the patient acceptable symptom state (PASS) (1), and low inflammation as CRP<10 mg/l (2). Baseline predictors of unacceptable pain, and of unacceptable pain with low inflammation, were evaluated using logistic regression analysis. Results: A total of 233 patients with early RA (73% female, 57% anti-CCP positive, mean age 60 years, median symptom duration 7 months) were included. Of these, 179 attended the 5-year follow-up. At 5 years, 34% had unacceptable pain, and 23% had unacceptable pain with low inflammation. High VAS scores for pain and patient's global assessment (PGA) at baseline were associated with unacceptable pain at 5 years (Table). There was a negative association between baseline swollen joint count (SJC28) and unacceptable pain at the 5 year follow-up. In multivariate logistic regression analysis including VAS PGA and SJC28, both had an impact on unacceptable pain after 5 years (adjusted odds ratios per standard deviation (SD), with 95% CI 1.78 (1.26-2.52) and 0.61 (0.42-0.89), respectively). Anti-CCP positive patients were significantly less likely to experience unacceptable pain with low inflammation at 5 years (Table). Conclusion: More than 1/3 of early RA patients experienced unacceptable pain after 5 years. Extensive synovitis in early RA was associated with a reduced risk of unacceptable pain at 5 years, likely due to positive effects of treatment on inflammation related pain. Non-inflammatory pain may be a greater long term problem in anti-CCP negative patients. References: [1] Tubach, et al. Arthritis Care Res2012; 64: 1699-707 [2] Lourdudoss, et al. Arthritis Care Res2018; 70: 205-12. Disclosure of Interests: Anna Eberhard: None declared, Tor Olofsson: None declared, Lennart T.H. Jacobsson Consultant for: LJ has received lecture and consulting fees from Pfizer, Abbvie, Novartis, Eli-Lily and Janssen, Carl Turesson: None declared